TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis
- 26 June 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 38 (48) , 3579-3587
Abstract
The recent failures of HDL-raising therapies have underscored our incomplete understanding of HDL biology. Therefore there is an urgent need to comprehensively investigate HDL metabolism to enable the development of effective HDL-centric therapies. To identify novel regulators of HDL metabolism, we performed a joint analysis of human genetic, transcriptomic, and plasma HDL-cholesterol (HDL-C) concentration data and identified a novel association between trafficking protein, kinesin binding 2 (TRAK2) and HDL-C concentration. Here we characterize the molecular basis of the novel association between TRAK2 and HDL-cholesterol concentration. Analysis of lymphocyte transcriptomic data together with plasma HDL from the San Antonio Family Heart Study (n = 1240) revealed a significant negative correlation between TRAK2 mRNA levels and HDL-C concentration, HDL particle diameter and HDL subspecies heterogeneity. TRAK2 siRNA-mediated knockdown significantly increased cholesterol efflux to apolipoprotein A-I and isolated HDL from human macrophage (THP-1) and liver (HepG2) cells by increasing the mRNA and protein expression of the cholesterol transporter ATP-binding cassette, sub-family A member 1 (ABCA1). The effect of TRAK2 knockdown on cholesterol efflux was abolished in the absence of ABCA1, indicating that TRAK2 functions in an ABCA1-dependent efflux pathway. TRAK2 knockdown significantly increased liver X receptor (LXR) binding at the ABCA1 promoter, establishing TRAK2 as a regulator of LXR-mediated transcription of ABCA1. We show, for the first time, that TRAK2 is a novel regulator of LXR-mediated ABCA1 expression, cholesterol efflux, and HDL biogenesis. TRAK2 may therefore be an important target in the development of anti-atherosclerotic therapies.Keywords
Funding Information
- National Health and Medical Research Council (GNT 1022812, GNT 1020284 and GNT1020285)
This publication has 25 references indexed in Scilit:
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- Trafficking Kinesin Protein (TRAK)-mediated Transport of Mitochondria in Axons of Hippocampal NeuronsJournal of Biological Chemistry, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Increased Cellular Free Cholesterol in Macrophage-specific Abca1 Knock-out Mice Enhances Pro-inflammatory Response of MacrophagesJournal of Biological Chemistry, 2008
- Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytesNature Genetics, 2007
- Transcriptional regulatory networks in lipid metabolism control ABCA1 expressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Cyclosporin A Traps ABCA1 at the Plasma Membrane and Inhibits ABCA1-Mediated Lipid Efflux to Apolipoprotein A-IArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X ReceptorJournal of Biological Chemistry, 2000
- Pathway of cholesterol efflux from human hepatoma cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995